Brendon Lange Neuen, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Renal Insufficiency, Chronic | 44 | 2024 | 2241 | 7.240 |
Why?
|
Diabetes Mellitus, Type 2 | 60 | 2024 | 12127 | 4.450 |
Why?
|
Glomerular Filtration Rate | 28 | 2024 | 2171 | 3.340 |
Why?
|
Cardiovascular Diseases | 40 | 2024 | 15476 | 2.360 |
Why?
|
Albuminuria | 11 | 2024 | 650 | 1.980 |
Why?
|
Kidney Failure, Chronic | 13 | 2023 | 2462 | 1.650 |
Why?
|
Diabetic Nephropathies | 10 | 2024 | 973 | 1.640 |
Why?
|
Cardiovascular System | 9 | 2023 | 835 | 1.600 |
Why?
|
Angioplasty, Balloon | 4 | 2014 | 588 | 1.410 |
Why?
|
Renal Dialysis | 7 | 2024 | 1795 | 1.170 |
Why?
|
Arteriovenous Shunt, Surgical | 4 | 2020 | 286 | 1.150 |
Why?
|
Kidney | 21 | 2024 | 7046 | 1.140 |
Why?
|
Vascular Patency | 3 | 2014 | 904 | 1.110 |
Why?
|
Graft Occlusion, Vascular | 3 | 2014 | 537 | 1.100 |
Why?
|
Kidney Diseases | 7 | 2023 | 2093 | 1.030 |
Why?
|
Creatinine | 6 | 2023 | 1898 | 0.960 |
Why?
|
Heart Failure | 16 | 2024 | 11653 | 0.960 |
Why?
|
Nephrology | 6 | 2020 | 263 | 0.910 |
Why?
|
Sodium-Glucose Transporter 2 | 6 | 2022 | 89 | 0.890 |
Why?
|
Hypokalemia | 1 | 2022 | 153 | 0.740 |
Why?
|
Randomized Controlled Trials as Topic | 14 | 2024 | 10180 | 0.690 |
Why?
|
Hyperkalemia | 1 | 2022 | 233 | 0.680 |
Why?
|
Angiotensin Receptor Antagonists | 5 | 2024 | 1031 | 0.610 |
Why?
|
Disease Progression | 9 | 2024 | 13484 | 0.600 |
Why?
|
Hypoglycemic Agents | 12 | 2024 | 3076 | 0.590 |
Why?
|
Symporters | 1 | 2020 | 361 | 0.590 |
Why?
|
Benzhydryl Compounds | 2 | 2023 | 916 | 0.570 |
Why?
|
Risk Adjustment | 1 | 2020 | 599 | 0.540 |
Why?
|
Fatty Liver | 1 | 2023 | 782 | 0.540 |
Why?
|
Metabolic Diseases | 1 | 2022 | 681 | 0.520 |
Why?
|
Sodium | 5 | 2023 | 1589 | 0.460 |
Why?
|
Metformin | 2 | 2024 | 905 | 0.450 |
Why?
|
Humans | 100 | 2024 | 760437 | 0.450 |
Why?
|
Arteriovenous Fistula | 1 | 2014 | 319 | 0.370 |
Why?
|
Biphenyl Compounds | 3 | 2024 | 1003 | 0.370 |
Why?
|
Drug Combinations | 3 | 2024 | 2043 | 0.340 |
Why?
|
Heart Diseases | 1 | 2022 | 2785 | 0.330 |
Why?
|
Queensland | 4 | 2020 | 52 | 0.330 |
Why?
|
Tetrazoles | 2 | 2024 | 907 | 0.300 |
Why?
|
Renin-Angiotensin System | 2 | 2023 | 737 | 0.300 |
Why?
|
Potassium | 2 | 2022 | 1311 | 0.290 |
Why?
|
Lymphocytes | 1 | 2015 | 2610 | 0.290 |
Why?
|
Glucose | 5 | 2023 | 4342 | 0.290 |
Why?
|
Treatment Outcome | 20 | 2024 | 64591 | 0.250 |
Why?
|
Double-Blind Method | 10 | 2024 | 12320 | 0.250 |
Why?
|
Internationality | 2 | 2020 | 1001 | 0.240 |
Why?
|
Hypertension | 2 | 2023 | 8527 | 0.230 |
Why?
|
Albumins | 2 | 2023 | 575 | 0.230 |
Why?
|
Male | 33 | 2024 | 360035 | 0.210 |
Why?
|
Neutrophils | 1 | 2015 | 3764 | 0.210 |
Why?
|
Female | 33 | 2024 | 391875 | 0.200 |
Why?
|
Middle Aged | 24 | 2024 | 220382 | 0.200 |
Why?
|
Antihypertensive Agents | 2 | 2022 | 2018 | 0.200 |
Why?
|
Risk Factors | 12 | 2023 | 74055 | 0.190 |
Why?
|
Naphthyridines | 1 | 2022 | 143 | 0.190 |
Why?
|
Soft Tissue Infections | 1 | 2023 | 168 | 0.190 |
Why?
|
Peripheral Arterial Disease | 2 | 2023 | 1271 | 0.190 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2023 | 363 | 0.180 |
Why?
|
Aged | 23 | 2024 | 168840 | 0.180 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 256 | 0.180 |
Why?
|
Renal Replacement Therapy | 2 | 2019 | 281 | 0.180 |
Why?
|
Atrial Fibrillation | 4 | 2023 | 5126 | 0.180 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 195 | 0.170 |
Why?
|
Atrial Flutter | 1 | 2022 | 252 | 0.170 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2024 | 1517 | 0.170 |
Why?
|
Health Services, Indigenous | 1 | 2020 | 47 | 0.170 |
Why?
|
Sodium Bicarbonate | 1 | 2019 | 60 | 0.170 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2021 | 345 | 0.170 |
Why?
|
Peritoneal Dialysis | 1 | 2020 | 159 | 0.160 |
Why?
|
Time Factors | 7 | 2024 | 39947 | 0.160 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2021 | 584 | 0.160 |
Why?
|
Urinalysis | 1 | 2021 | 368 | 0.160 |
Why?
|
Glucosides | 1 | 2023 | 512 | 0.160 |
Why?
|
Hospitalization | 6 | 2024 | 10698 | 0.150 |
Why?
|
Blood Pressure | 2 | 2023 | 8479 | 0.150 |
Why?
|
Health Services Accessibility | 5 | 2021 | 5421 | 0.140 |
Why?
|
Renal Insufficiency | 1 | 2023 | 809 | 0.140 |
Why?
|
Immunosuppressive Agents | 2 | 2021 | 4168 | 0.140 |
Why?
|
Lupus Nephritis | 1 | 2020 | 317 | 0.140 |
Why?
|
Patients | 1 | 2023 | 905 | 0.140 |
Why?
|
Stroke Volume | 3 | 2024 | 5487 | 0.130 |
Why?
|
Jejunal Neoplasms | 1 | 2015 | 19 | 0.130 |
Why?
|
Fibrosis | 1 | 2023 | 2048 | 0.130 |
Why?
|
Risk Assessment | 5 | 2024 | 23953 | 0.120 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2017 | 335 | 0.110 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1703 | 0.110 |
Why?
|
Program Development | 1 | 2019 | 1297 | 0.110 |
Why?
|
Australia | 3 | 2022 | 1245 | 0.110 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11453 | 0.100 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 5835 | 0.100 |
Why?
|
Intestinal Obstruction | 1 | 2015 | 432 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2015 | 1596 | 0.100 |
Why?
|
Developing Countries | 5 | 2021 | 2882 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2019 | 1202 | 0.090 |
Why?
|
Anemia | 1 | 2020 | 1508 | 0.090 |
Why?
|
Blood Glucose | 2 | 2021 | 6380 | 0.090 |
Why?
|
Stroke | 2 | 2022 | 9745 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1127 | 0.080 |
Why?
|
Mortality | 1 | 2020 | 2897 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2022 | 3048 | 0.080 |
Why?
|
Bibliometrics | 1 | 2011 | 350 | 0.070 |
Why?
|
Developed Countries | 2 | 2020 | 445 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12429 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4789 | 0.070 |
Why?
|
Cost Sharing | 2 | 2020 | 409 | 0.070 |
Why?
|
Diabetic Angiopathies | 2 | 2024 | 804 | 0.070 |
Why?
|
Pilot Projects | 1 | 2019 | 8611 | 0.070 |
Why?
|
Bayes Theorem | 2 | 2024 | 2326 | 0.060 |
Why?
|
Costs and Cost Analysis | 2 | 2020 | 1668 | 0.060 |
Why?
|
New South Wales | 1 | 2024 | 69 | 0.060 |
Why?
|
Cost of Illness | 1 | 2013 | 1931 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6471 | 0.060 |
Why?
|
Anticoagulants | 1 | 2019 | 4806 | 0.060 |
Why?
|
England | 1 | 2024 | 527 | 0.050 |
Why?
|
Interleukin-6 | 2 | 2023 | 3209 | 0.050 |
Why?
|
State Medicine | 1 | 2024 | 214 | 0.050 |
Why?
|
Research | 1 | 2011 | 1977 | 0.050 |
Why?
|
Mineralocorticoids | 1 | 2022 | 37 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 26063 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 29551 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39078 | 0.050 |
Why?
|
Ferritins | 1 | 2023 | 597 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12054 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2015 | 3159 | 0.040 |
Why?
|
Erythropoiesis | 1 | 2023 | 682 | 0.040 |
Why?
|
Transportation of Patients | 1 | 2020 | 174 | 0.040 |
Why?
|
Incidence | 3 | 2023 | 21322 | 0.040 |
Why?
|
Administrative Personnel | 1 | 2020 | 184 | 0.040 |
Why?
|
Spironolactone | 1 | 2022 | 411 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4241 | 0.040 |
Why?
|
Health Expenditures | 2 | 2020 | 2353 | 0.040 |
Why?
|
Diuretics | 1 | 2021 | 610 | 0.040 |
Why?
|
Staff Development | 1 | 2019 | 228 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1524 | 0.040 |
Why?
|
Prospective Studies | 4 | 2024 | 54339 | 0.040 |
Why?
|
Placebos | 1 | 2021 | 1661 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1376 | 0.030 |
Why?
|
Cohort Studies | 3 | 2024 | 41366 | 0.030 |
Why?
|
Quality of Health Care | 2 | 2020 | 4316 | 0.030 |
Why?
|
Iron | 1 | 2023 | 1787 | 0.030 |
Why?
|
Child | 1 | 2023 | 80086 | 0.030 |
Why?
|
Adult | 5 | 2024 | 220781 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2024 | 80430 | 0.030 |
Why?
|
Thromboembolism | 1 | 2019 | 996 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4614 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58859 | 0.020 |
Why?
|
Remission Induction | 1 | 2017 | 2394 | 0.020 |
Why?
|
History, 21st Century | 1 | 2017 | 1567 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4010 | 0.020 |
Why?
|
Nephrectomy | 1 | 2015 | 934 | 0.020 |
Why?
|
History, 20th Century | 1 | 2017 | 2770 | 0.020 |
Why?
|
Intestine, Small | 1 | 2015 | 1205 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4226 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4116 | 0.020 |
Why?
|
Health Policy | 1 | 2020 | 2680 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 7996 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2975 | 0.020 |
Why?
|
Insulin | 1 | 2021 | 6591 | 0.020 |
Why?
|
Body Mass Index | 1 | 2023 | 12932 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3904 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10494 | 0.020 |
Why?
|
Inflammation | 1 | 2023 | 10746 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15820 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5332 | 0.010 |
Why?
|
Physicians | 1 | 2020 | 4586 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18379 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12918 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 59068 | 0.010 |
Why?
|